SC junks pleas for panel to examine faulty drug approvals

Image
Press Trust of India New Delhi
Last Updated : Mar 11 2016 | 9:03 PM IST
The Supreme Court has dismissed PILs seeking creation of a framework for recalling drugs and setting up of a commission to examine faulty drug approvals.
A bench headed by Chief Justice T S Thakur junked the pleas saying it does not have time to take up matters raised by public activists for publicity and also questioned the "locus standi" of the petitioner.
"An overseas citizen has to come all the way to challenge a rule. What is your locus?" the bench asked, adding "Bring a public person affected by the rule."
The Union Health Ministry, the Drugs Consultative Committee and the Central Drugs Standard Control Organization (CDSCO) were among the respondents in the case.
The bench also said, "You (petitioner) are coming with academic issues when people are languishing in jails. Our hands are full," the bench dismissed these petitions as withdrawn by the party after the petitioner's counsel requested he be allowed to approach other forums including the high court.
The pleas challenged certain rules under the Drugs and Cosmetics Act.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 11 2016 | 9:03 PM IST

Next Story